(Press-News.org) High blood sugar is a defining characteristic of Type 2 diabetes and the cause of many of the condition's complications, including kidney failure, heart disease, and blindness. Most diabetes medications aim to maintain normal blood sugar (glucose) levels and prevent high blood sugar by controlling insulin.
A new University of Iowa study shows that another biological checkpoint, known as the Mitochondrial Pyruvate Carrier (MPC), is critical for controlling glucose production in the liver and could potentially be a new target for drugs to treat diabetes.
The study, led by Eric Taylor, PhD, UI assistant professor of biochemistry, and published Sept. 3 in the journal Cell Metabolism, shows that disabling MPC reduces blood sugar levels in mouse models of Type 2 diabetes.
Glucose is primarily made in the liver and requires the molecular building blocks to pass through specialized cellular compartments called mitochondria. Mitochondria use a small molecule called pyruvate as the starting point for synthesizing glucose, and the pyruvate is imported into the mitochondria through the MPC portal.
Taylor and his colleagues showed that disabling the MPC in mouse livers shuts down this major route of glucose production. However, because glucose is a critical cellular fuel, there are "back-up" mechanisms. When the MPC was disabled in mouse livers, another glucose-producing mechanism was activated to compensate. This alternative mechanism uses molecules from protein as the building blocks for glucose.
"Essentially, what we found is that disruption of the MPC makes the liver less efficient at making glucose and, as a result, the liver burns more fat for energy, makes less cholesterol, and makes less glucose in models of diabetes," explains Taylor, who also is a member of the Fraternal Order of Eagles Diabetes Research Center at the UI. "This overall change in metabolism matches outcomes that would be therapeutically desirable for people with diabetes."
The new research is based on earlier work by Taylor's group and others, which identified the genes for MPC. In the new study, the UI researchers use this genetic information to specifically disrupt MPC activity in animal models. They found that disrupting MPC in normal mice doesn't cause low blood sugar, or hypoglycemia, which would be important for the safety of any new treatment targeting MPC. In mouse models of Type 2 diabetes, however, loss of the MPC activity in the liver decreases high blood sugar and improves glucose tolerance. The study also suggests that MPC activity contributes to excess glucose production and high blood sugar levels in Type 2 diabetes.
The therapeutic potential of targeting glucose production in the liver is supported by the fact that metformin, the most widely used and staple treatment for Type 2 diabetes, also decreases glucose synthesis in the liver by disrupting mitochondrial metabolism, although the exact mechanisms underlying this drug's action on mitochondria are controversial.
However, Taylor cautions that additional research will be required to determine if inhibiting MPC activity might be a safe approach for human therapies, especially in people under high levels of physical stress or with other medical complications.
The team plans to extend their studies to cultured human liver cells to determine if disabling the MPC produces the same metabolic effects as seen in the mouse studies, and to make sure that inhibiting this checkpoint does not produce dangerous side effects.
INFORMATION:
The multidisciplinary research team included UI researchers from the departments of Biochemistry, Pharmacology, Pediatrics, and Internal Medicine many of whom are affiliated with the Fraternal Order of Eagles Diabetes Research Center at the UI and the Francois Abboud Cardiovascular Research Center. Scientists from University of Texas Southwestern Medical Center, University of Utah, and Cell Signaling Technology, Inc. in Massachusetts, also were part of the team.
The study was supported in part by grants from National Institutes of Health, Robert A. Welch Foundation, Edward Mallinckrodt Jr. Foundation, and the American Diabetes Association.
LAWRENCE -- Researchers at the University of Kansas working with an international team at the Large Hadron Collider have produced quark-gluon plasma -- a state of matter thought to have existed right at the birth of the universe -- with fewer particles than previously thought possible.
The material was discovered by colliding protons with lead nuclei at high energy inside the supercollider's Compact Muon Solenoid detector. Physicists have dubbed the resulting plasma the "littlest liquid."
"Before the CMS experimental results, it had been thought the medium created in ...
DARIEN, IL - A new study shows that high school students lose sleep on school nights following the change to daylight saving time that occurs in March. The loss of sleep during the school week was associated with a decline in vigilance and cognitive function, which raises safety concerns for teen drivers.
Results show that the average objectively measured sleep duration on the weeknights after the spring time change declined to 7 hours, 19 minutes, which reflects a mean loss of 32 minutes per night compared with the school week prior to the implementation of daylight ...
MADISON, Wis. - Orchids, a fantastically complicated and diverse group of flowering plants, have long blended the exotic with the beautiful. Most species live on trees, often in remote, tropical mountains. Their flowers can be strange -- one even flowers underground, and many species deceive their pollinators into thinking they are good to eat.
Some are florist's staples, like phalaenopsis, the hot-pink and white flower that is easy to grow and easier to sell. Beyond the "job" of looking beautiful, only the vanilla orchids have any commercial role.
The estimated ...
Repeated exposure to anesthesia early in life causes alterations in emotional behavior that may persist long-term, according to a study from the Icahn School of Medicine at Mount Sinai in collaboration with the Yerkes National Primate Research Center, and published in the Online First edition of Anesthesiology, the official medical journal of the American Society of Anesthesiologists®.
Each year, approximately one million children under the age of four undergo surgery with general anesthesia, according to the U.S. Food and Drug Administration (FDA). Retrospective ...
A study that used stored blood samples from U.S. Air Force personnel who conducted aerial herbicide spray missions of Agent Orange during the Vietnam war found a more than 2-fold increased risk of the precursor to multiple myeloma known as monoclonal gammopathy of undetermined significance (MGUS), according to an article published online by JAMA Oncology.
While the cause of MGUS and multiple myeloma (plasma cell cancer) remains largely unclear, studies have reported an elevated risk of multiple myeloma among farmers and other agricultural workers and pesticides have ...
CAMBRIDGE, Mass. -- The technology behind 3-D printing is growing more and more common, but the ability to create designs for it is not. Any but the simplest designs require expertise with computer-aided design (CAD) applications, and even for the experts, the design process is immensely time consuming.
Researchers at MIT and the Interdisciplinary Center Herzliya in Israel aim to change that, with a new system that automatically turns CAD files into visual models that users can modify in real time, simply by moving virtual sliders on a Web page. Once the design meets ...
CAMBRIDGE, Mass. (September 3, 2015) - In the breast, cancer stem cells and normal stem cells can arise from different cell types but tap into distinct yet related stem cell programs, according to Whitehead Institute researchers. The differences between these stem cell programs may be significant enough to be exploited by future therapeutics.
Deadly tumor-initiating cells seed metastases throughout the body and cause relapses in patients. Whether these tumor-initiating cells can also be referred to as stem cells, specifically, cancer stem cells, has been up for debate. ...
A brief series of classes to help first-time parents better support each other through the often stressful transition to parenthood has a positive effect on birth outcomes as well, according to health researchers.
A decade ago Mark Feinberg, research professor at the Bennett Pierce Prevention Research Center for the Promotion of Human Development, Penn State, developed Family Foundations, a series of classes for expectant parents. In two research trials, the program was shown to improve the way parents support each other -- to reduce parental stress, depression and anxiety; ...
AUSTIN, Texas -- Evidence from the tropical lowlands of Central America reveals how Maya activity more than 2,000 years ago not only contributed to the decline of their environment but continues to influence today's environmental conditions, according to researchers at The University of Texas at Austin.
Synthesizing old and new data, researchers were the first to show the full extent of the "Mayacene" as a microcosm of the early anthropocene -- a period when human activity began greatly affecting environmental conditions.
"Most popular sources talk about the anthropocene ...
In some patients, aggressive cancers can become resistant to chemotherapy and radiation treatments. In a paper published in the journal Nature Communications, University of California, San Diego School of Medicine researchers identified a pathway that causes the resistance and a new therapeutic drug that targets this pathway.
"It was previously known that RAF (a family of proteins that regulate cellular signaling) governs resistance to therapies. We discovered an undescribed role for RAF and learned precisely how it occurs in a broad range of cancers," said lead author ...
